bf/NASDAQ:MTEM_icon.jpeg

NASDAQ:MTEM

Molecular Templates, Inc.

  • Stock

USD

Last Close

0.00

01/05 20:00

Market Cap

8.93M

Beta: 1.37

Volume Today

5

Avg: 814.27K

PE Ratio

−0.91

PFCF: −0.35

OverviewFinancialsAPI

    Description

    Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that...Show More

    Earnings

    Earnings per Share (Estimate*)

    -10-552019-11-122021-05-132023-03-302024-05-132024-12-27

    Revenue (Estimate*)

    5M10M15M20M25M30M35M2019-11-122021-05-132023-03-302024-05-132024-12-27

    *Estimate based on analyst consensus